About Us

Archives






Ocugen, Inc. Announces Ken Inchausti as Head, Investor Relations & Communications

Posted: June 22, 2021 at 1:50 am


MALVERN, Pa., June 21, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that Ken Inchausti has joined the company as Head, Investor Relations & Communications. Mr. Inchausti will oversee the company’s investor relations activities, corporate communications and strategic positioning, leading issues management strategy and proactive media and social media relations programming.

More here:
Ocugen, Inc. Announces Ken Inchausti as Head, Investor Relations & Communications

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.